Disclosed positions

Estimated from their latest filings — positions may have changed since

$4.18M

combined est. value

Stock	Shares	Price	Value	Weight	As of
OCULOCULAR THERAPEUTIX, INC	246,933	$10.33	$2.55M	61%	2026-02-20
LNSRLENSAR, Inc.	263,831	$6.19	$1.63M	39%	2026-06-03

OCUL

OCULAR THERAPEUTIX, INC

$2.55M

246,933 sh

LNSR

LENSAR, Inc.

$1.63M

263,831 sh

Activity

Open-market buy & sell volume

BuySell

Total +$461.4K bought

Most bought

OCUL

$461.4K

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 1sells 0

Stock	Transaction	Date	~6mo later
LNSRLENSAR, Inc.	Grant — · 17,421 sh	2026-06-03	—
OCULOCULAR THERAPEUTIX, INC	Buy $461.4K · 60,229 sh	2026-02-20	in progress
OCULOCULAR THERAPEUTIX, INC	Grant — · 14,000 sh	2025-06-11	—
LNSRLENSAR, Inc.	Grant — · 7,374 sh	2025-05-23	—

LNSRGrant

2026-06-03 · LENSAR, Inc.

17,421

—

OCULBuy

2026-02-20 · OCULAR THERAPEUTIX, INC

$461.4K

in progress

OCULGrant

2025-06-11 · OCULAR THERAPEUTIX, INC

14,000

—

LNSRGrant

2025-05-23 · LENSAR, Inc.

7,374

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.